PMID: 8601226Apr 1, 1996Paper

Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
A M Downs, I de Vincenzi

Abstract

The objective of this study was to investigate the relationship between the number of unprotected heterosexual contacts with an HIV-infected person and the probability of HIV transmission. Data from a European study involving 563 heterosexual partners of HIV-infected subjects were analyzed. The number of unprotected contacts could be estimated for 525 couples (377 with male index case, 148 with female index case) from the reported frequency of unprotected contacts and an estimate of the length of the period during which transmission could have occurred. Nonparametric (isotonic regression) and parametric (Bernoulli model) analyses were performed on data at study entry and on follow-up data (121 couples). The nonparametric analysis resulted in several exposure groups, with the proportion of infected partners increasing with the number of contacts. For example, the percentage of female partners infected ranged from 10%, among those with < 10 unprotected contacts with an infected male, to 23% after 2,000 unprotected contacts. The parametric estimates of (assumed constant) per-contact infectivity were higher for male-to-female than for female-to-male transmission, but not significantly so. However, in comparison with nonparametric e...Continue Reading

Associated Clinical Trials

References

Oct 14, 1992·JAMA : the Journal of the American Medical Association·H W Haverkos, R J Battjes
Oct 14, 1992·JAMA : the Journal of the American Medical Association·A Phillips, A Johnson
May 1, 1990·The Journal of Infectious Diseases·N S PadianN P Jewell
Jan 1, 1989·Journal of Clinical Epidemiology·V DeGruttolaC R Horsburgh
Jan 1, 1988·JAMA : the Journal of the American Medical Association·T A PetermanJ W Curran
Jun 9, 1988·Nature·R M Anderson, R M May
Aug 14, 1987·JAMA : the Journal of the American Medical Association·N PadianW Winkelstein
Jan 22, 1994·Lancet·T D MastroI M Longini
Aug 11, 1994·The New England Journal of Medicine·A M Johnson

❮ Previous
Next ❯

Citations

Jan 1, 1997·Springer Seminars in Immunopathology·W A Paxton, R A Koup
Aug 11, 2005·Current HIV/AIDS Reports·Mitchell H Katz, Julie Louise Gerberding
Nov 16, 2002·Current Infectious Disease Reports·Mitchell H. Katz, Julie Louise Gerberding
Sep 3, 2011·Demography·Jeremy R Magruder
Apr 16, 1998·Obstetrics and Gynecology·P M WortleyP L Fleming
Jan 6, 2001·Infectious Disease Clinics of North America·M E Blocker, M S Cohen
Nov 30, 1998·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·G PerezD B Louria
Apr 10, 1997·The New England Journal of Medicine·R A RoyceM S Cohen
Jan 13, 2006·Sexual Health·Michelle GilesSuzanne Garland
Feb 9, 2006·Population Studies·M Giovanna MerliJing Li
Feb 25, 2003·The Journal of Infectious Diseases·Barbra A RichardsonJoan K Kreiss
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Centers for Disease Control and PreventionUNKNOWN HIV Prevention in Clinical Care Working Group
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jared M BaetenJulie Overbaugh
Jan 14, 2012·The Journal of Infectious Diseases·James P HughesUNKNOWN Partners in Prevention HSV/HIV Transmission Study Team
May 2, 2002·Sexually Transmitted Diseases·Steven D PinkertonUNKNOWN NIMH multisite HIV prevention trial group
Jan 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·P L Vernazza, J J Eron
Mar 1, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·P L VernazzaW Pichler
Dec 22, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S C Shiboski, N S Padian
Jul 27, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·D Gisselquist
Apr 19, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·D C Bell, R A Trevino
Dec 5, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S D PinkertonJ B Jemmott
Jul 21, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S F LockettA J Leigh Brown
Mar 2, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Hong-Ha M TruongLawrence Corey
Dec 11, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mark P HawkenMarleen Temmerman
Mar 17, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S M MehendaleR C Bollinger
May 8, 2008·Current Opinion in Obstetrics & Gynecology·Valeria SavasiEnrico Ferrazzi
Mar 20, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Gregory S ZaricDouglas K Owens
Apr 8, 2003·Ethics & Behavior·Thomas V Palma, Richard J Iannelli
Mar 15, 2014·PLoS Computational Biology·Nico J D NagelkerkeSake J de Vlas
Nov 22, 2011·Future Medicinal Chemistry·Joanna S OlsenStephen Dewhurst
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michelle E RolandJeffrey N Martin
May 30, 2003·American Journal of Public Health·Harrell W ChessonGeorge W Counts
Nov 5, 2011·Journal of Pediatric and Adolescent Gynecology·R J DiclementeJ M Sales

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.